T. Rowe Price Associates
OSCR icon

T. Rowe Price Associates’s Oscar Health OSCR Stock Holding History

T. Rowe Price Associates’s Portfolio OSCR Stock Details OSCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$92.9M Buy
3,255,724
+1,341,822
+70% +$28.9M 0.01% 718
2026
Q1 		$22M Sell
1,913,902
-846,863
-31% -$11.9M ﹤0.01% 1014
2025
Q4 		$39.7M Sell
2,760,765
-238,853
-8% -$4.13M ﹤0.01% 876
2025
Q3 		$56.8M Buy
2,999,618
+2,319,254
+341% +$38.2M 0.01% 766
2025
Q2 		$14.6M Sell
680,364
-2,644,932
-80% -$39.3M ﹤0.01% 1037
2025
Q1 		$43.6M Sell
3,325,296
-1,419,606
-30% -$21.1M 0.01% 761
2024
Q4 		$63.8M Sell
4,744,902
-643,159
-12% -$10.4M 0.01% 677
2024
Q3 		$114M Buy
5,388,061
+431,626
+9% +$7.77M 0.01% 539
2024
Q2 		$78.4M Buy
4,956,435
+978,283
+25% +$18M 0.01% 600
2024
Q1 		$59.2M Buy
3,978,152
+2,409,160
+154% +$33M 0.01% 681
2023
Q4 		$14.4M Buy
1,568,992
+704,913
+82% +$4.86M ﹤0.01% 1027
2023
Q3 		$4.81M Buy
864,079
+813,456
+1,607% +$5.69M ﹤0.01% 1190
2023
Q2 		$409K Buy
50,623
+5,601
+12% +$41.3K ﹤0.01% 2225
2023
Q1 		$295K Buy
45,022
+1,651
+4% +$6.74K ﹤0.01% 2352
2022
Q4 		$107K Sell
43,371
-90,735
-68% -$284K ﹤0.01% 2705
2022
Q3 		$670K Sell
134,106
-288,226
-68% -$1.68M ﹤0.01% 1976
2022
Q2 		$1.79M Buy
422,332
+292,016
+224% +$1.86M ﹤0.01% 1650
2022
Q1 		$1.3M Buy
130,316
+2,000
+2% +$14.9K ﹤0.01% 1871
2021
Q4 		$1.01M Sell
128,316
-24,828
-16% -$312K ﹤0.01% 2039
2021
Q3 		$2.66M Sell
153,144
-234,887
-61% -$3.98M ﹤0.01% 1629
2021
Q2 		$8.34M Sell
388,031
-113,632
-23% -$2.72M ﹤0.01% 1437
2021
Q1 		$13.5M Buy
+501,663
New +$15.7M ﹤0.01% 1345

Other funds holding OSCR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
TCMNY
Thrive Capital Management (New York) New York $3.81B AUM 45.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates's OSCR Position: Q2 2026 in Review

T. Rowe Price Associates increased its Oscar Health (OSCR) stake by 70% in Q2 2026, buying an estimated $28.9M and bringing the position to 3,255,724 shares worth $92.9M. The position accounts for 0.01% of the portfolio, ranked #718.

T. Rowe Price Associates first reported a position in OSCR in Q1 2021 and has held it in 22 quarters since. The position peaked at $114M in Q3 2024. 402 funds tracked by Wall St. Rank hold OSCR as of Q2 2026.

  • T. Rowe Price Associates held 3,255,724 shares of Oscar Health worth $92.9M as of Q2 2026.
  • T. Rowe Price Associates bought 1,341,822 Oscar Health shares in Q2 2026, an estimated $28.9M.
  • Oscar Health made up 0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #718 holding.
  • T. Rowe Price Associates first reported a position in Oscar Health in Q1 2021 and has held it in 22 quarters since.
  • T. Rowe Price Associates's Oscar Health position peaked at $114M in Q3 2024.
  • 402 funds tracked by Wall St. Rank held Oscar Health as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.